Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,063 results that match your search.22,063 results
  • Patent litigation is becoming more popular in the Czech Republic. Karel Cermak Jr of Cermak Horejs Myslil in Prague provides a guide for potential litigants
  • A wealth of IP rights exists in innovations from the developing world, particularly in biodiversity inventions. The battle has always been to secure access to those rights. India’s Honey Bee Network is one organization fighting for a fairer system. Ralph Cunningham reports
  • Latha R reviews the protection for freelancers in India in the light of the recent US decisions in Tasini and Greenberg
  • A cigarette company has proved use to fight off an attempt to register a mark similar to one of its products. This is in spite of failing with its own application. Owners of foreign trade marks in Singapore should gain confidence from the result, writes Farah Namazie
  • Better safe than sorry: even companies with no immediate intention of doing business in China should register their trade marks there. If not they could find themselves paying a lot of money in the future to prove fame, warns Gary Fechter
  • On May 7 the European Group on Ethics in Science and New Technologies (EGE) presented to the Commission its latest opinion 'Ethical aspects of patenting involving human stem cells'. The opinion aims to define the conditions and limits of the patenting of stem cells.
  • Section 3 (1) of the 1994 German Trade Mark Act provides that "any signs, particularly words ... including colours and combinations of colours, which are capable of distinguishing the goods or services of one undertaking from those of other undertakings may be protected as trade marks." With this wording the 1994 statute exceeds the standards given by article 2 of the European Council Directive.
  • The EU Biotechnology Directive (98/44/EC) was controversial in the making and remains so. The member states of the EU had until July 31 2000 to transpose the Biotechnology Directive into their national legal systems. So far only five of them have done so.
  • Patent applications in biotechnology have grown dramatically in the past decade, throwing up many challenges and posing new problems for patent offices. Ingrid Hering speaks to examiners at the EPO and USPTO to find out how they are dealing with these issues
  • The International Trademark Association (INTA) hosted a session at the WTO Doha Symposium in Geneva from April 29 to May 1 on the impact of the Doha Agreement on geographical indications (GIs). The session revealed a divergence between the EU and US. The EU proposes that GI protection should be available for all products; the US maintains that only wines and spirits should benefit.